More NO-No more ROS - Combined selective mineralocorticoid receptor blockade and angiotensin-converting enzyme inhibition for vascular protection

被引：7

作者：

Bauersachs, Johann ^{[1
]}

Fraccarollo, Daniela ^{[1
]}

机构：

[1] Univ Wurzburg, Univ Klinikum, Med Klin & Poliklin 1, D-97080 Wurzburg, Germany

来源：

HYPERTENSION | 2008年 / 51卷 / 03期

关键词：

D O I：

10.1161/HYPERTENSIONAHA.107.106625

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：624 / 625

页数：2

共 12 条

[1] Anglotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function - A systematic review and meta-analysis of randomized controlled trials [J].

Al-Mallah, MH ;

Tleyjeh, IM ;

Abdel-Latif, AA ;

Weaver, WD .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) :1576-1583

[2] Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats [J].

Bachetti, T ;

Comini, L ;

Pasini, E ;

Cargnoni, A ;

Curello, S ;

Ferrari, R .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (03) :395-403

[3] Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction - Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression [J].

Bauersachs, J ;

Heck, M ;

Fraccarollo, D ;

Hildemann, SK ;

Ertl, G ;

Wehling, M ;

Christ, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :351-358

[4] Mineralocorticoid receptors and cardiovascular damage - It's not just aldosterone [J].

Funder, JW .

HYPERTENSION, 2006, 47 (04) :634-635

[5] Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability [J].

Imanishi, Toshio ;

Ikejima, Hideyuki ;

Tsujioka, Hiroto ;

Kuroi, Akio ;

Kobayashi, Katsunobu ;

Muragaki, Yasuteru ;

Mochizuki, Seiichi ;

Goto, Masami ;

Yoshida, Kiyoshi ;

Akasaka, Takashi .

HYPERTENSION, 2008, 51 (03) :734-741

[6] Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells [J].

Jaffe, IZ ;

Mendelsohn, ME .

CIRCULATION RESEARCH, 2005, 96 (06) :643-650

[7] Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells [J].

Mazak, I ;

Fiebeler, A ;

Muller, DN ;

Park, JK ;

Shagdarsuren, E ;

Lindschau, C ;

Dechend, R ;

Viedt, C ;

Pilz, B ;

Haller, H ;

Luft, FC .

CIRCULATION, 2004, 109 (22) :2792-2800

[8] Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [J].

Milliez, P ;

Girerd, X ;

Plouin, PF ;

Blacher, J ;

Safar, ME ;

Mourad, JJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1243-1248

[9] Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity [J].

Nagata, Daisuke ;

Takahashi, Masao ;

Sawai, Kuniko ;

Tagami, Tetsuya ;

Usui, Takeshi ;

Shimatsu, Akira ;

Hirata, Yasunobu ;

Naruse, Mitsuhide .

HYPERTENSION, 2006, 48 (01) :165-171

[10] Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction [J].

Sartorio, Carmem Luiza ;

Fraccarollo, Daniela ;

Galuppo, Paolo ;

Leutke, Meike ;

Ertl, Georg ;

Stefanon, Ivanita ;

Bauersachs, Johann .

HYPERTENSION, 2007, 50 (05) :919-925

← 1 2 →